Intranasal Oxytocin for Methamphetamine Withdrawal in Women

Exclusion Criteria

• •Non-English-speaking women.
• •Women lactating, pregnant or of childbearing potential who are not willing to use an effective means of contraception for the duration of the trial.
• •Meeting DSM-5 criteria for moderate-severe substance use disorder other than methamphetamine, nicotine and cannabis, as assessed by treating physician on pre-admission to residential withdrawal.
• •Clinically significant or unmanaged medical or psychiatric illness (e.g., renal insufficiency, cirrhosis, unstable hypertension, unstable diabetes mellitus, seizure disorder, history of DSM-5 psychotic or bipolar disorder, current severe major depression, current suicidal ideation), assessed by treating physician on pre-admission to residential withdrawal.
• •Current participation in another trial.